Th1 and Th2 cytokine responses after measles antigen stimulation in vitro in bone marrow transplant patients: Response to measles vaccination

Bone Marrow Transplantation

Volumn 20, Issue 4, 1997, Pages 317-323

  Pauksen, K ^a   Sjolin J ^a   Linde, A ^b   Alm, G ^c   Andersson, B ^d   Lonnerholm G ^a   Ljungman, P ^e  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d CALAB Medical Laboratories   (Sweden)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Immunity; Interferon ; Interleukin 10; Interleukin 12; Measles; Vaccination

Indexed keywords

ALPHA INTERFERON; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; MEASLES VACCINE; VIRUS ANTIGEN;

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW TRANSPLANTATION; CELLULAR IMMUNITY; CHILD; HELPER CELL; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOSTIMULATION; MAJOR CLINICAL STUDY; MEASLES; MEASLES VACCINATION; MEASLES VIRUS; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 1842407196     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700903     Document Type: Article

References (39)

1. Panum PL. Observation made during the epidemic of measles on the Faeroe Islands in the year 1846. Med Classics 1939; 2: 839-886.
2. Bech V. Measles epidemic in Greenland. Am J Dis Child 1962; 103: 252-253.
3. Dai B, Chen ZH, Liu QC et al. Duration of immunity following immunization with live measles vaccine: 15 years of observation in Zhejiang Province, China. Bull World Health Org 1991; 69: 415-423.
4. Reyes MA, Franky de Borrero M, Roa J et al. Measles vaccine failure after documented seroconversion. Pediatr Infect Dis J 1987; 6: 848-851.
5. Pauksen K, Duraj V, Ljungman P et al. Immunity to and immunization against measles, rubella and mumps in patients after autologous bone marrow transplantation. Bone Marrow Transplant 1992; 9: 427-432.
6. Ljungman P, Lewensohn-Fuchs I, Hammarstöm V et al. Long-term immunity to measles, mumps, and rubella after allogneic bone marrow transplantation. Blood 1994; 84: 657-663.
7. Pauksen K, Linde A, Ljungman P et al. Specific T and B cell immunity to measles after allogeneic and autologous bone marrow transplantation. Bone Marrow Transplant 1995; 16: 807-813.
8. Pauksen K, Sjölin J, Lönnerholm G et al. Influence of the specific T cell response on seroconversion after measles vaccination in transplanted patients. Bone Marrow Transplant 1996; 18: 969-973.
9. Mosmann TR, Cherwinski H, Bond MW et al. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986; 136: 2348-2357.
10. Yssel H, de Waal Malefyt R, Roncarolo MG et al. IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells. J Immunol 1992; 149: 2378-2384.
11. Del Prete G, de Carli M, Almerigogna F et al. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 1993; 150: 353-360.
12. Mosmann TR. Cytokine secretion patterns and cross-regulation of T cell subsets. Immunol Res 1991; 10: 183-188.
13. Gajewski TF, Fitch FW. Anti-proliferative effect of IFN-γ in immune regulation. I. IFN-γ inhibits the proliferation of TH2 but not TH1 murine helper T lymphocyte clones. J Immunol 1988; 140: 4245-4252.
14. Sieling PA, Abrams JS, Yamamura M et al. Immunosuppressive roles for IL-10 and IL-4 in human infection. In vitro modulation of T cell responses in leprosy. J Immunol 1993; 150: 5501-5510.
15. Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse helper cells. IV. Th2 clone secretes a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989; 170: 2081-2095.
16. Bogdan C, Vodovotz Y, Nathan C. Macrophage deactivation by interleukin 10. J Exp Med 1991; 174: 1549-1555.
17. Ward BJ, Griffin DE. Changes in cytokine production after measles virus vaccination: predominant production of IL-4 suggests induction of a Th2 response. Clin Immunol lmmunopathol 1993; 67: 171-177.
18. Griffin DE, Ward BJ. Differential CD4 T cell activation in measles. J Infect Dis 1993; 168: 275-281.
19. Trinchieri G. Interleukin-12: a cytokine produced by antigenpresenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 1994; 84: 4008-4027.
20. Fitzgerald-Bocarsly P. Human natural interferon-α producing cells. Pharm Ther 1993; 60: 39-62.
21. Brinkmann V, Geiger T, Alkan S, Heusser CH. Interferon α increases the frequency of interferon-γ producing human CD4+ T cells. J Exp Med 1993; 178: 1655-1663.
22. Ringdén O, Pihlstedt P, Markling L et al. Prevention of graftversus-host disease with T-cell depletion or cyclosporin and methotrexate. A randomized trial in adult leukemic marrow recipients. Bone Marrow Transplant 1991; 7: 221-226.
23. Lönnerholm G, Carlsson K. Bäcklund L et al. Renal function after autologous bone marrow transplantation. Bone Marrow Transplant 1991; 8: 129-134.
24. Simonsson B, Burnett AK, Prentice HG et al. Autologous bone marrow transplantation with monoclonal antibody purged marrow for high risk acute lymphoblastic leukemia. Leukemia 1989; 3: 631-636.
25. Christenson B, Böttiger M. Methods for screening the naturally acquired and vaccine-induced immunity to the measles virus. Biologicals 1990; 18: 207-211.
26. Ljungman P, Lönnqvist B, Gahrton G et al. Clinical and subclinical reactivations of varicellae-zoster virus in immunocompromised patients. J Infect Dis 1986; 153: 840-847.
27. Ljungman P, Lönnqvist B, Wahren B et al. Lymphocyte responses after cytomegalovirus infection in bone marrow transplant recipients - a one-year follow-up. Transplantation 1985; 40: 515-520.
28. Griffin DE, Ward BJ, Jauregui E et al. Immune activation during measles. New Engl J Med 1989; 320: 1667-1672.
29. Artursson K, Lindersson M, Varela N et al. Interferon-α production and tissue localization of interferon-a/b producing cells after intradermal administration of Aujeszky's disease virus-infected cells in pigs. Scand J lmmunol 1995; 41: 121-129.
30. Ward BJ, Johnson RT, Vaisberg A et al. Spontaneous proliferation of peripheral mononuclear cells in natural measles virus infection: identification of dividing cells and correlation with mitogen responsiveness. Clin lmmunol Immunopathol 1990; 55: 315-326.
31. Farrar MA, Schreiber RD. The molecular cell biology of interferon-γ and its receptor. Ann Rev lmmunol 1993; 11: 571-611.
32. Borysiewicz LK, Morris S, Page JD. Sissons JGP. Human cytomegalovirus-specific cytotoxic T lymphocytes: requirements for in vitro generation and specificity. Eur J lmmunol 1993; 13: 804-809.
33. Moore KW. O'Garra A, de Waal Malefyt R et al. Interleukin-10. Ann Rev Immunol 1993; 11: 165-190.
34. D'Andre A, Rengaraju M, Valiante NM et al. Production of natural killer cell stimulatory factor (interleukin-12) by peripheral blood mononuclear cells. J Exp Med 1992; 176: 1387-1398.
35. Karp CL, Wysocka M, Wahl LM et al. Mechanism of suppression of cell-mediated immunity by measles virus. Science 1996; 273: 228-231.
36. Nakayama T, Urano T, Osano M et al. Evaluation of live trivalent vaccine of measles AIK-C strain, mumps Hoshino strain and rubella Takahsahsi strain, by virus specific interferon-gamma production and antibody response. Microbiol Immunol 1990; 34: 497-508.
37. Ward BJ, Boulianne S, Ratnam S et al. Cellular immunity in measles vaccine failure: demonstration of measles antigen-specific lymphoproliferative responses despite limited serum antibody production after revaccination. J Infect Dis 1995; 172: 1591-1595.
38. Kaplan LJ, Daum RS, Smaron M et al. Severe measles in immunocompromised patients. JAMA 1992; 267: 1237-1241.
39. Good RA, Zak SJ. Disturbance in gammaglobulin synthesis as 'experiments of nature'. Pediatrics 1956; 18: 109-149.